Sold by: Next Move Strategy Consulting
Deployed on AWS
The designer phages market, valued at USD 1.57 billion in 2024, is projected to reach USD 2.49 billion by 2030, with a CAGR of 8.0%. Driven by healthcare spending, infectious disease prevalence, and agricultural applications, the market faces regulatory challenges but benefits from innovations in phage display technology, with strong growth in North America, Europe, and Asia-Pacific.
Overview
The global Designer Phages Market is experiencing robust growth, valued at USD 1.57 billion in 2024 and projected to reach USD 1.70 billion in 2025 and USD 2.49 billion by 2030, with a compound annual growth rate (CAGR) of 8.0% from 2025 to 2030. This expansion is driven by increasing healthcare investments, the rising prevalence of infectious diseases, and the growing adoption of phages in agriculture to combat plant diseases and pests. Designer phages, engineered to target specific pathogens, offer precise and adaptive solutions to address antimicrobial resistance and sustainable crop protection. While stringent regulatory requirements pose challenges, advancements in phage display technology and genetic engineering are creating significant growth opportunities across medical, agricultural, and industrial applications.
Download FREE Sample: https://www.nextmsc.com/designer-phages-market-hc3524/request-sample
Increased healthcare spending is a major driver of market growth, fueling research and development of innovative therapies. In the U.S., national health expenditure is expected to grow at 5.8% annually from 2024 to 2033, outpacing GDP growth and increasing healthcare GDP share to 20.3% by 2033. This financial commitment supports the development and commercialization of designer phages, particularly for targeting antibiotic-resistant infections and oncology applications. Robust funding, such as the USD 300 million allocated to the National Institutes of Health in 2024, accelerates the pipeline for phage-based therapeutics, positioning them as a critical component of next-generation biologics and driving market expansion.
The rising incidence of infectious diseases, coupled with antimicrobial resistance, is propelling demand for designer phages. Global HIV/AIDS-related deaths are projected to reach 6.5 million by 2030 under a baseline scenario, highlighting the growing burden of infectious diseases. Conventional treatments are losing efficacy due to resistance, creating an urgent need for targeted therapies. Designer phages offer a highly specific approach, capable of eliminating pathogens without harming beneficial bacteria, making them a promising solution for diseases like tuberculosis, hepatitis, and drug-resistant infections. This escalating health crisis underscores the importance of phages in modern infectious disease management.
Inquire Before Buying: https://www.nextmsc.com/designer-phages-market-hc3524/inquire-before-buying
In agriculture, designer phages are gaining traction as a sustainable alternative to chemical pesticides, addressing plant diseases and pest infestations. With global food security challenges and increasing resistance to traditional treatments, phages provide an eco-friendly solution for crop protection and aquaculture. Their ability to target specific pathogens without disrupting ecosystems aligns with the growing emphasis on sustainable agriculture. This versatility across medical and agricultural applications positions designer phages as a transformative technology, driving market demand in regions with significant agricultural activity, such as Asia-Pacific and Latin America.
Stringent regulatory requirements present a challenge, as the lack of standardized global frameworks delays approvals and increases development costs. Regulatory complexity discourages investment and slows commercialization, particularly for novel phage therapies. However, advancements in phage display technology, such as those demonstrated by the 2024 collaboration between University Medical Center Utrecht and Delft University, are creating opportunities. These innovations enable the engineering of broadly acting phages, enhancing their efficacy in therapeutics, diagnostics, and biocontrol, and paving the way for expanded applications in biotechnology and agriculture.
Access Full Report: https://www.nextmsc.com/report/designer-phages-market-hc3524
Regionally, North America leads the market due to significant healthcare investments and a high prevalence of diseases like cancer and antibiotic-resistant infections. European market growth is driven by antimicrobial resistance concerns, with over 35,000 annual deaths in the EU/EEA, and supportive EU initiatives like Horizon Europe. Asia-Pacific is the fastest-growing region, fueled by an aging population and rising healthcare needs, with Indian elderly population projected to double by 2050. In the Rest of the World, Latin America, the Middle East, and Africa are seeing increased adoption due to infectious disease burdens and the need for sustainable agricultural solutions.
Details
Delivery method
Deployed on AWS
New
Introducing multi-product solutions
You can now purchase comprehensive solutions tailored to use cases and industries.
Features and programs
Financing for AWS Marketplace purchases
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
Pricing
This product is available free of charge. Free subscriptions have no end date and may be canceled any time.
Additional AWS infrastructure costs may apply. Use the AWS Pricing Calculator to estimate your infrastructure costs.
Vendor refund policy
All sales are final; no refunds or returns are accepted. Our reports include sensitive, researched data from various sources, including industry experts and paid services. We ensure confidentiality and offer customization at an additional cost. Please review our terms before purchase. For inquiries, contact customer service.
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA) .
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |
Resources
Vendor resources
Similar products
Personalized support from an Elastic expert familiar with your environment and business goals for faster issue resolution and targeted guidance.
The Generative AI Pathfinder Workshop by zeb propels your business into the AI-driven future with AWS. In this collaborative workshop, you'll delve into the essentials of generative AI (use case discovery, model selection, prompt engineering, etc.) to innovate and refine your AI strategy. Deliverables encompass a future-state architecture diagram, strategic recommendations, TCO estimation, and an implementation proposal, all customized to your business objectives. Unleash the power of generative AI to unlock new opportunities and drive transformative growth.
The F5 NGINX Designated Engineer (DE) offering provides you with a highly skilled professional with a broad and deep technical understanding of NGINX that will help you obtain your business and technical needs.
An affordable and flexible remote consulting service that aligns F5 expertise with
your environment while expanding your knowledge of F5 technology
Capital Harness Designer enables engineers to create detailed, validated and manufacturing-ready harness designs. You can tailor the tool to meet your specific needs. The rules-based collaborative design merge functions provide automated integration of multi-source design inputs at a detailed level.